Mirae Asset Global Investments’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-18,604
| Closed | -$2M | – | 2733 |
|
|
2023
Q1 | $2M | Buy |
18,604
+2,553
| +16% | +$274K | ﹤0.01% | 1204 |
|
|
2022
Q4 | $1.77M | Buy |
16,051
+2,241
| +16% | +$247K | ﹤0.01% | 1210 |
|
|
2022
Q3 | $815K | Buy |
13,810
+3,761
| +37% | +$222K | ﹤0.01% | 1599 |
|
|
2022
Q2 | $283K | Buy |
+10,049
| New | +$283K | ﹤0.01% | 2017 |
|